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Summary 
This review deals with the duality of enterococci, which can be illustrated 
by their yin - yang behaviour. The rough nature of this specific group of lactic 
acid bacteria promotes their dissemination in various environments where 
they significantly influence the outcome of a certain process. In the 
technological meaning, enterococci are leading microbes in fermentation 
processes of traditional foods, where their detrimental spoilage activities are 
equally significant. As therapeutics, enterococci manifest the probiotic 
properties through their positive effects on maintaining of the normal 
intestinal microflora, on stimulation of the immune system, on improved 
nutritional value of food and with the production of antimicrobial compounds 
(bacteriocins). At the same time, enterococci present an emerging pool of 
opportunistic pathogens for humans as they cause disease, possess agents for 
antibiotic resistance and their transfer mechanisms, and are frequently armed 
with potential virulence factors. Despite the yin - yang characteristics of 
enterococci, the long history of safe use of certain strains of enterococci in 
food/feed, and reliable identification and classification of enterococci with 
phenotypic methods supported with modern genetic tools, enables selection of 
promising enterococci, which could be safely used as starter cultures or 
food/feed additives.  




Enterococci are notorious as ubiquitous microbes inhabiting soil, food, 
water and gastrointestinal (GI) tract of humans and animals. Genus 
Enterococcus currently comprises more than 26 species, with E. faecalis and 
E. faecium being two predominant species mostly found, especially in food 
(Giraffa, 2003; Klein, 2003). 
Because of their abundance in different ecological niches, enterococci are 
significant in environmental, food and clinical microbiology. From the 
technological point of view they play an important role in the production of 




A. Čanžek Majhenič: Enterococci: yin-yang… Mljekarstvo 56 (1) 5-20, 2006. 
 
2001; Andrighetto et al., 2001) where they are, on the other hand, also 
associated with spoilage of foods, especially meats (Franz et al., 1999). 
Another beneficial effect of enterococci is seen in their probiotic function, 
which is claimed to include maintenance of the normal intestinal microflora, 
stimulation of the immune system and improvement of foods nutritional value 
(Franz, 1999). Unlike their health promoting activities, certain enterococcal 
strains can cause human disease such as endocarditis, bacteraemia, urinary 
tract and neonatal infections. A specific cause for concern is their resistance to 
a wide variety of antibiotics. The intrinsic resistance of enterococci to a variety 
of antibiotics is mediated by genes chromosomally located while acquired 
resistance is mediated by genes residing on plasmids or transposons which can 
be transferred vertically and horizontally among bacteria (Kayser, 2003). 
Enterococci are also known to harbour useful biotechnological traits, such as 
production of bacteriocins, called enterocins. According to published reports, 
some enterocins have been described as antimicrobial peptides active against 
closely related and other lactic acid bacteria, listeria and clostridia, and 
therefore show potential in food control strategy (Giraffa, 1995).  
The duality of enterococci rise doubts about their use as probiotics, as 
starter cultures in the food industry or as animal feed additives. Fortunately, 
the development of modern identification and classification methods together 
with clinical trials and long history of safe use of particular enterococci in 
production of traditional fermented foods classify enterococci as microbes 
with no particular risk for human health. However, the exact characterisation 
and safety assessment of a strain is crucial step needed prior any selection of 
strain in human or animal purposes. For instance, Enterococcus faecium SF68 
has been studied and well documented over a period of more than 20 years for 
use as a human probiotic, especially in the treatment of diarrhoea (Franz, 
1999).  
Traditional fermented products offer a remarkable reservoir of "natural" 
microbes, including enterococci. With the use of proper phenotypic and 
molecular techniques, interesting and safe enterococci with potential use as 
starter cultures or as feed additives can be described and selected. Moreover, 
selection of natural isolates significantly contributes to the preservation and 
protection of the diversity and autochthonism of enterococci that are 
responsible for the deliciousness of traditional fermented products.  
Irrespective of their yin-yang nature, enterococci remain one of the 
leading microbes concerning clinical, food and environmental future 
perspectives. Clearly, before application of enterococci in the dairy products, 
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review is focused on balanced evaluation of both, beneficial and detrimental 
nature of enterococci, because only clear understanding of their status may 
allow their safe use as a starter, or supportive cultures.  
Enterococci - the ubiquitous microorganisms 
It is well known that enterococci are natural inhabitants in soil, food, 
water and in GI tract of humans and animals, mostly mammals and birds. The 
main reason for their successful survival and persistence in such 
microbiologically diverse environments is in their rough nature. Enterococci 
are resistant to drying, heat and sanitazing agents. They grow from 10 to 45 
°C, survive heating at 62.8 °C for 30 min, tolerate 6.5 % NaCl and 40 % bile, 
grow between pH 4.0 and 9.6 (Stiles, 2002) and can therefore efficiently 
compete for nutrients and space.  
Enterococci were formerly classified as "faecal" or Lancefield group D 
streptococci which indicate that, despite enterococcal dissemination, the 
predominant habitat of enterococci still remains the gastrointestinal tract of 
humans and animals. Good adaptation on rigorous intestinal conditions gives 
enterococci excellent opportunity for their activities, whether beneficial or 
adverse. Moreover, faecal contamination seems to be one of the most 
important routes for their spreading, especially in various foods from animal 
origin. For a long time, the presence of enterococci in foods served as an 
indicator of poor hygiene, but nowadays enterococci are recognised as normal 
parts of the food microflora (Franz et al., 1999).  
The environmental abundance and activities of enterococci have excited 
their high respect among scientists. Therefore, many researches have been 
lately focused on detailed identification and characterisation of this interesting 
group of microorganisms. 
Beneficial activities of enterococci 
From the positive side enterococci are closely involved with the 
production of traditional fermented foods, specially cheeses and meats. They 
colonise raw foods of animal origin (milk, meat) through intestinal and/or 
environmental contamination, where can survive and multiply during 
fermentation processes. The biochemical activities of enterococci in sausage 
matrix have not been studied thoroughly, but they might contribute to sausage 
aromatisation by their glycolytic, proteolytic and lipolytic activities (Hugas et 
al., 2003). Enterococci occur and grow in a variety of artisanal cheeses, 
produced from raw or pasteurised milk. Their historical bad reputation of 
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the ripened cheeses bacterial flora. Enterococci show higher proteolytic 
activities than other lactic acid bacteria (LAB) which is important for cheese 
ripening. Their beneficial effect in cheese making has also been attributed to 
hydrolysis of milk fat by esterases. Additionally, enterococci produce typical 
flavour components such as acetaldehyde, acetoin and diacetyl. This beneficial 
role of enterococci in development of cheese aroma has led to inclusion of 
enterococcal strains in certain starter cultures (Franz et al., 1999). For 
example, two cheese isolates, E. faecium FAIR-E 198, a strain isolated from 
Greek Feta cheese, and E. faecium FAIR-E 243, a strain isolated from 
Sardinian cheese, were proposed to be applied as adjunct starter in Greek Feta 
cheese making for their positive impact during the ripening. Based on the 
overall evaluation of the results obtained from the microbiological, 
physicochemical and sensorial analyses, the most pronounced impact of both 
E. faecium strains, either as sole adjunct starter or in combination, has been 
observed on the growth of the starter culture, casein degradation and the 
organoleptic properties of the mature cheese (Sarantinopoulos et al., 
2002a). Similarly, in Tetilla cheese production, an ideal starter should include 
Lc. lactis subsp. lactis and selected enterococci with the aim of achieving a 
high lipolysis and specific proteolysis over αS1-casein (Menendez et al., 
2004). Nevertheless, many reports describe the abundance of enterococci in 
traditional cheeses thus fortifying their position as normal part of cheese 
microflora, with E. faecalis being the predominant species (Andrighetto et 
al., 2001; Čanžek Majhenič  et al., 2005). 
Therapeutic properties of enterococci manifest through probiotic activities 
including maintenance or restoration of the normal intestinal microflora and 
thereby prevention or reduction of gastro-intestinal disorders, alleviation of 
lactose intolerance, reduction in serum cholesterol levels, anticarcinogenic 
activity, stimulation of the immune system and improved nutritional value of 
foods (Franz et al., 1999). Most probiotic LAB strains derive from healthy 
humans and are therefore naturally associated with the mucosal surfaces of the 
mouth, GI and genitourinary tract, where they are present as typical 
commensals. Enterococci are minority (up to 1%), but important members of 
the bacterial community inhabiting large bowel of adult humans with E. 
faecalis, E. faecium and E. durans as prevailing species (Tannock and 
Cook, 2002). Products for human consumption containing probiotic orga-
nisms are most often sold as infant foods, cultured milks and pharmaceutical 
preparations/animal feed additives where few strains of E. faecium and E. 
faecalis find application. E. faecium SF68 is probably the best studied in terms 
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was shown to be effective in the treatment of intestinal disorders. This strain is 
also resistant to low pH, insensitive to bile salts and individuals show a high 
tolerance to it, with no side effects (Franz et al., 1999). Another controlled 
studies revealed that E. faecium SF68 significantly reduced the incidence of 
diarrhoea in chronic pulmonary tuberculosis patients receiving long-term 
treatment. It was also effective as lactulose in lowering blood ammonia and for 
improving mental state and psychometric performance of patients with hepatic 
encephalopathy. At present, there are no unified regulations available 
concerning correct labelling, safety and functionality of the commercially 
available probiotic preparations. Labelling issue and antibiotic susceptibility of 
bacterial isolates (including E. faecium) of 55 probiotic products has been 
recently reviewed by Temmerman et al. (2003), where they conclude that 
quite a number of products are incorrectly or inadequately labelled, as well as 
certain strains showed antibiotic resistance. It is important that probiotic 
products designed especially for their health promoting purposes are safe and 
well-documented in order to provide consumers with the full benefits of the 
probiotic aspects. 
Another common and beneficial trait among enterococci seems to be 
bacteriocin production. These, so called enterocins, are mainly produced by E. 
faecalis and E. faecium strains and generally belong to class II bacteriocins 
which are regarded as small, heat stable and membrane active non-lantibiotics 
(van Belkum and Stiles, 2000). From the very beginning of enterococcal 
bacteriocins researches, enterocins have been frequently reported as 
bacteriocins with antilisterial effect (Giraffa, 1995). Concerning the latter, 
inhibition of L. monocytogenes and other Listeria spp. by enterococci gives the 
essential information on their interest as food-grade preservatives, to be used 
in dairy technology. Two main applications concerning bacteriocins are 
possible: the use of either antimicrobial proteins as additives or bacterio-
cinogenic strains directly in food system. Many reports consider possible use 
of enterocins/bacteriocinogenic enterococci as starters in different food 
models, where can efficiently serve as a barrier in a hurdle technology 
(Laukova et al., 1999a; Laukova et al., 1999b; Sarantinopoulos et al., 
2002b; Foulquie Moreno et al., 2003; Sabia et al., 2003). Moreover, 
enterococcal isolates, selected from slovenian traditional Karst ewe's cheese, 
exerted strong antilisterial effect which could be a result of bacteriocinogenic 
activity (Mohar et al., 2005). Well-characterised Enterococcus bacteriocins 
are enterocin A, enterocin B, enterocin 50, bacteriocin 31 and enterocin AS-48 
(Franz et al., 1999). In their research, Rodriguez et al. (2000) confirmed 




A. Čanžek Majhenič: Enterococci: yin-yang… Mljekarstvo 56 (1) 5-20, 2006. 
 
inhibitory activity against both spoilage and pathogenic microorganisms. 
Moreover, AS-48 producing enterococci have been found at high proportion 
especially in goats' and ewes' milk. Enterocins with broad inhibitory spectra 
undoubtly indicate their use as biopreservative agents in dairy systems. As 
proposed by Giraffa (1995), careful identification followed by thorough 
testing based upon certain criteria must be accomplished before putting any of 
enterocins (or enterocin producing strains) to practical use in the dairy 
industry.  
Detrimental activities of enterococci 
Unlike their positive technological traits, enterococci can become a 
spoilage problem in traditionally fermented meat products and also in cooked, 
processed meats, especially if initially present in high numbers (Giraffa, 
2002). The persistence of enterococci in fermented meat products can be 
attributed to their wide range of growth temperatures and their high tolerance 
to salt (Hugas et al., 2003). According to some authors, formation of biogenic 
amines seems to be unfavourable activity of enterococci in fermented meat 
products, where microbial growth, acidification and proteolysis offer 
propitious conditions for biogenic amines production. All non-starter 
enterococci, isolated from fermented pork sausages, were reported to produce 
tyramine and phenylethylamine, while no tryptamine, putrescine or cadaverine 
was detected (Bover-Cid et al., 2001). The prolific growth of enterococci of 
a dairy origin in milk and milk products leading to formation of significant 
levels of biogenic amines has been observed as well (Martuscelli  et al., 
2005).  
According to many authors, enterococci numbers vary from 104 to 106 
CFU/g in cheese curd and from 105 to 107 CFU/g in the fully ripened cheese 
(Franz et al., 1999; Giraffa, 2003). Similar observations were recently 
reported for Tolminc, an artisanal Slovenian cheese, where in fully ripened 
cheese enterococci reached numbers of up to 106 per g (Čanžek Majhenič  
et al., 2005). Varying levels in different cheeses result from the cheese type, 
the production season, the extent of milk contamination, and survival in the 
dairy environment (dependent on seasonal temperature), as well as survival 
and growth under the particular conditions of cheese manufacture and ripening 
(Foulquie Moreno et al., 2006). High levels of contaminating enterococci, 
most often caused by poor hygienic practices during cheese manufacture, lead 
to deterioration of sensory properties in some cheeses. It is known that casein 
degradation performed by enterococci play an important role in the 
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level as some peptides contribute to the formation of flavour, while others, 
undesirable bitter-tasting peptides can lead to off-flavours. Concerning the 
lipolytic activity of enterococci in cheese, limited and even contradictory data 
appears in the literature. Lipids in cheese contribute to cheese flavour as being 
source of fatty acids, which may be further converted to methyl ketones and 
lactones, being a cause of oxidation of fatty acids, leading to the formation of 
unsaturated and flavoured aldehydes causing a flavour defect referred to as 
oxidative rancidity, and being solvents for aromatic compounds of fatty acids 
(Foulquie Moreno et al., 2006). 
More seriously, a number of nosocomial infections such as endocarditis, 
bacteraemia, urinary tract and neonatal infections have been associated with an 
increasing incidence of enterococci, predominantly strains of E. faecalis and, 
to a lesser extent, E. faecium. Over the last two decades, enterococci, formerly 
viewed as organisms of minimal clinical impact, have emerged as 
opportunistic pathogens of humans. Major risk factors for acquiring 
nosocomial enterococcal infections are serious underlying disease, a long 
hospital stay, renal insufficiency, neutropenia, liver or bone marrow 
transplantation, presence of urinary or vascular catheters, treatment in an 
intensive care facility, and a preceding antibiotic therapy for other infectious 
diseases with antibiotics against which enterococci possess a natural 
resistance. In this connection, superinfections with enterococci can occur 
(Kayser, 2003).  
The virulence gene expression 
 Enterococci are intrinsically (naturally) resistant to a number of 
antibiotics, which are mediated by genes located on the chromosome. This is 
distinct from acquired resistance that is mediated by genes residing on 
plasmids or transposons. Acquired resistance can occur if two prerequisites are 
present: the genetic potential by the microorganisms (accumulation of 
mutations in the "own" DNA that finally leads to resistance or acquisition of 
transferable resistance genes from donor cells) and the antibiotic selective 
pressure (therapeutic use of antibiotics) (Klare et al., 2003). Examples of 
intrinsic antibiotic resistance include resistance to cephalosporins, β-lactams, 
sulphonamides and low levels of clindamycin and aminoglycosides, while 
examples of acquired resistance include resistance to chloramphenicol, 
erythromycin, high levels of β-lactams, fluoroquinolones and glycopeptides, 
such as vancomycin (Franz et al., 2003). Vancomycin resistance is of special 
concern because this antibiotic was considered a last resort for treatment of 
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resistant enterococci (VRE) in hospitals has led to serious infections that 
cannot be treated with conventional antibiotic therapy. Today, 6 different gene 
clusters mediating glycopeptide resistance have been described in enterococci: 
vanA, vanB, vanD, vanE and vanG which are known to be acquired traits, 
while vanC is an intrinsic property of motile enterococci. The vanA cluster 
mediates high-level inducible resistance to both glycopeptides (vancomycin 
and teicoplanin), while vanB cluster causes inducible low- to high-level 
resistance to vancomycin only. vanA and vanB resistance are usually acquired 
through the Tn1546 transposon. vanD, vanE and vanG clusters do not appear 
to be transferable (Kak and Chow, 2002). The vanA type of enterococcal 
glycopeptide resistance is the most important one and its main reservoir is E. 
faecium (Klare et al., 2003). Many debates concerning the source of VRE 
have been opened, but it seems that farm animals, due to the avoparcin use 
(glycopeptide antibiotic used as a growth promoter in animal feeds), constitute 
an important reservoir of VRE that could be transmitted to the hospital 
environment via contaminated meat (Franz et al., 1999). Besides VRE, 
isolated from a wide variety of farm animals, there are some reports on 
traditional European cheeses dealing with detection of multiple drug resistant 
enterococci. The later indicates strong correlation between the use of 
antibiotics in human medicine and animal husbandry, and opens the question 
on their entering to the food chain. Moreover, some authors isolated VRE 
from healthy subjects living in the community and with no history of 
hospitalisation or antibiotic treatment. This suggests that development of 
strains resistant to antibiotics is not a phenomenon restricted to hospitals and 
that the food chain may play a role in spreading the glycopeptide-resistant 
enterococci (Mannu et al., 2003) Therefore, enterococci can be naturally 
transmitted from food animals or foods to the human intestinal tract. 
Antibiotic resistance alone cannot explain the virulence of enterococci. In 
order to become pathogenic, they need to express virulence traits associated 
with adhesion, translocation and evasion of immune response and cause 
pathological changes either directly by toxin production or indirectly by 
inflammation (Franz et al., 2003). Known virulence traits in enterococci 
include adherence to host tissues where aggregation substance (agg) and 
extracellular surface protein (esp) play a mayor role, production of adhesin-
like E. faecalis and E. faecium endocarditis antigens (efaAfs, efaAfm), 
secretion of cytolysin (cyl) and other toxic products (gelE protease) and 
production of plasmid-encoded sex pheromones (cpd, cob, ccf, cad). Cytolysin 
is responsible for lysing a broad range of eukaryotic and gram-positive cells, 
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pheromones facilitate conjugation (Eaton and Gasson, 2001). Although 
mechanisms of acquisition of antibiotic resistance and spread have been well 
studied and enterococcal virulence and pathogenic mechanisms are still largely 
unknown, some facts concerning virulence determinants are ascertained. 
When Eaton and Gasson (2001) investigated the incidence of known 
virulence determinants in starter, food, and medical strains of E. faecalis and 
E. faecium, they have found that medical E. faecalis strains had more 
virulence determinants than food strains did, which in turn, had more than 
starter strains did. E. faecium strains were generally free of virulence 
determinants, with notable exceptions. gelE and esp determinants were found 
in E. faecium strains from all three origins, although in the past, these were 
found exclusively in E. faecalis strains. This phenomenon could be related to 
the increasing occurrence of pathogenic E. faecium strains. efaA determinant 
was found at similar frequencies in the E. faecalis and E. faecium strains and 
appears in all three groups. Similar distribution of virulence determinants was 
determined for E. faecalis strains isolated from Tolminc traditional Slovene 
cheese (Čanžek Majhenič  et al., 2005). On the other hand, low incidence of 
virulence determinants in E. faecium from dairy, ovine and medical strains 
was reported by Mannu et al. (2003) as no strain carried more than one 
virulence determinant. Moreover, among enterococci isolated from food, 
Franz et al. (2001) observed, that 10.4 % of E. faecium strains were positive 
for one or more virulence determinant, compared to 78.7 % of E. faecalis 
strains.  
Regarding to all written down, the question whether enterococci are safe 
for use as starter cultures remains difficult to answer. The principal concern 
for enterococci in the food supply is their pathogenic potential based on 
horizontal transfer of genes for factors associated with virulence and antibiotic 
resistance. With in vitro studies, Eaton and Gasson (2001) were able to 
show that virulence genes on a pheromone-responsive plasmid could be 
transferred to strains of E. faecalis used as started cultures in food, but they 
were not able to transfer virulence genes into strains of E. faecium starter 
cultures. However, present evidence does not suggest enterococci as 
foodborne pathogens, but the food chain has clearly been established as an 
important source of enterococci in human environment, where some strains 
may bear antibiotic resistance and virulence traits. The control and safety of 
foods that contain enterococci is a special challenge to food industry because 
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How to distinguish the good guys from the bad guys? 
Fortunately, this question is not doubtful anymore because of available 
identification and classification methods, including modern phenotypic and 
powerful molecular tools (for review see Domig et al., 2003).  
Besides fundamental differentiation of enterococci, well known 
phenotypic typing methods are used as follows: biotyping, meaning the 
detection of carbohydrate fermentation and enzyme pattern, usually includes a 
battery of bacteriological tubes containing different carbohydrate sources and 
indicator dyes. Most of the commercially available kits are indicator-based 
determination of sugar utilisation or show reactions based on their specific 
microbial enzymes, and are known as: api 20 Strep (Bio-Merieux, Mracy 
l'Etoile, France), api 50 CH (Bio-Merieux), Rapid ID32 Strep (Bio-Merieux) 
and api zym (Bio-Merieux). Recently, PhenePlate™ PhP plate system 
(PhPlate Microplate Techniques, Stockholm, Sweden) proved successful for 
environmental (Čanžek Majhenič  et al., 2005) and epidemiological studies 
of enterococcal isolates, yielding results similar to those obtained by pulsed-
field gel electrophoresis (PFGE) (Kuhn et al., 1995). Another phenotypic 
method is sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) which compares the whole-cell protein patterns of unknown isolates 
on the species and/or subspecies level (Descheemaeker et al., 1994). 
Among other typing methods there are multilocus enzyme electrophoresis 
(MLEE), antimicrobial susceptibility testing, serotyping, long-chain fatty acid 
analysis, fatty acid methyl esters (FAME) analysis, enterocin typing, pyrolysis 
mass spectrometry (pyMS), vibrational spectroscopic methods and proton 
magnetic resonance spectroscopy (1H MRS) (Domig et al., 2003). 
More rapid and reliable identification and differentiation of strains is 
conducted by application of molecular biology techniques. The first generation 
of genotypic typing methods based on the analysis of plasmid content and 
plasmid DNA restriction digests. Next step of typing methods included total 
chromosomal restriction digests, known as DNA fingerprint or profile, and 
analysis of restriction fragment length polymorphism (RPFL) by hybridisation 
with probes (eg. ribotyping). The development of pulsed-filed gel 
electrophoresis (PFGE), which allows global chromosomal comparisons, in 
the mid-1980s ushered in the third generation of genetic methods together with 
the discovery of polymerase chain reaction (PCR) and consecutively most 
PCR-based amplification methods: randomly amplified polymorphic DNA 
(RAPD), specific and random amplification (SARA-PCR), amplified fragment 
length polymorphism (AFLP), Rep-PCR, PCR-ribotyping, amplification of 
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restriction analysis (ARDRA), RFLP of PCR-amplified 16 S rDNA, broad 
range PCR-restriction fragment length polymorphism (PCR-RFLP), temporal 
temperature gradient gel electrophoresis (TGGE), denaturing gradient gel 
electrophoresis (DGGE). The most sophisticated, fourth generation approaches 
base on multilocus sequence typing (MLTS) and DNA sequencing (Domig et 
al., 2003).  
From this brief overview it can concluded that the importance and 
applicability of each of the methods may vary from one species to another, and 
also according to the precise geographical location in which they are being 
used. For some species, combined use of several different phenotypic methods 
may offer a reasonable approach, but such an approach may not be possible, or 
may take a long time to develop, for organisms which have not been well-
studied previously. In contrast, genotypic methods have potential to be used 
for studying diversity in any microbial species, with some genotypic methods 
also offering the possibility of providing the universal approach to microbial 
typing in which the same basic methodology can be used to study isolates of 
any microorganism. Namely, PCR identification of enterococci with genus-
specific primers, designed by Deasy et al. (2000) from published 16 S rRNA, 
enables specific discrimination of Enterococcus genus from other bacteria. 
These primers were also used to characterise the enterococcal diversity in an 
Irish cheddar-type cheese-making factory (Gelsomino et al., 2001). To 
characterise clinically relevant enterococci, Dutka-Malen et al. (1995) 
developed primers at the species level (E. faecalis and E. faecium), targeting 
the ddl gene. E. durans and E. hirane species specific primers, targeting ddl 
gene as well, were developed and validated by Knijff et al. (2001). Many 
publications report PCR detection of van genes in enterococci with variations 
of vanA, vanB, vanC1, vanC2 and vanC3 primers that originally were all 
derived from the sequences designed by Dutka-Malen et al. (1995). A 
molecular screening of Enterococcus virulence determinants using PCR 
technique was performed by Eaton and Gasson (2001). Moreover, 
Hufnagel et al. (2003) propose an additional immunological test to assess the 
safety of enterococci by testing the susceptibility to opsonophagocytic killing. 
In recent study of Cocolin et al. (2004), DGGE method seems to efficiently 
differentiate and identify E. faecium and E. faecalis.  
New knowledge, new methods and techniques, development and 
improvement of analysing procedures, which are gained on daily bases, widen 
our perspectives in detection, characterisation and identification of enterococci 
in the area of food microbiology and in epidemiological researches. Only well-
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can provide reliable identification of a certain strain of enterococci that could 
be used as a starter culture or as probiotic preparation.  
Conclusions 
It appears that there is a very thin line separating enterococci-
contaminants from enterococci-pathogens. The emergence of many 
enterococci resistant to glycopeptides and other antibiotics, production of 
biogenic amines into the food, and finding of virulence traits within both 
clinical and foodborne isolates pose the presence of enterococci in foods 
questionable (Giraffa, 2003). Moreover, highly efficient ability of 
enterococci to transfer different genes, e.g. antibiotic resistance genes, to 
pathogenic bacteria, even more decrease the beneficial credit of enterococci. 
As such, they could constitute a definite health risk and special care should be 
taken to ensure that enterococci used as probiotics or starter cultures do not 
posses potential virulence factors or acquire antibiotic resistance. Therefore 
the question of whether enterococci are safe for use in food/feed could only be 
answered after thorough and explicit setting up of selection criteria defining 
which enterococci are not pathogenic. Growing range of techniques with 
varying taxonomical resolution is used to identify, characterise and type 
enterococci. Genotypic methods, in particular, have become a powerful tool in 
food microbiology and in epidemiological search of enterococci, and can 
scientifically support discrimination between beneficial and detrimental 
enterococci regarding the testing schemes, which so far are not mandatory in 
the food legislation of the EU. 
Despite their detrimental nature, enterococci definitely find application as 
technological microorganisms, especially in cheese and meat fermentation 
processes. It has to be emphasized that in the most traditional food 
fermentation studies so far, enterococci are proposed to be a part of defined 
microbial population, where they appear to play at least some positive role. 
Low milk acidifying and proteolytic activities make enterococci of minor 
importance as primary starter cultures in cheese manufacture, but they are 
significant as starter adjuncts. In cheeses made with added enterococci, taste, 
aroma, colour, structure, as well as the overall sensory profile of ripened 
cheese seem to be positively affected (Giraffa, 2003).  Moreover, some 
strains with a long history of safe use as probiotics and their large-scale 
commercial application are also known. For example, E. faecium SF68 has 
more than 20-year-long history of safe association in probiotic therapy. 
Numerous strains of enterococci associated with food systems produce 
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aureus, Clostridium spp. (Giraffa, 1995). Therefore enterocins or enterocin 
producers show a potential for dairy application as biopreservatives or 
protective cultures.  
However, based on a long history of safe association of particular 
enterococci with some traditional food fermentations, the use of such strains 
appears to bear no particular risk for human health. Abundance of experiences 
as well as progress in molecular techniques enables exact characterisation and 
safety assessment of a strain. Therefore, the yin-yang duality of enterococci 
should not be our stoic dark future but challenging and promising present as 
we posses tools and knowledge to command enterococci. 
ENTEROKOKI: YIN - YANG MIKROBI 
Sažetak 
Ovaj revijalni prikaz opisuje dualizam enterokoka kojega možemo 
ilustrirati njihovim yin-yang ponašanjem. Otporna narav ove veoma specifične 
skupine bakterija mliječne kiseline omogućava njihovu proširenost u različitim 
sredinama gdje signifikantno utječu na ishod pojedinih procesa. Tako su u 
tehnološkom smislu enterokoki vodeći mikrobi u fermentacijskim procesima a 
istovremeno su i dobro poznati uzročnici kvarenja hrane. Kao terapeutici, 
enterokoki manifestiraju svoja probiotička svojstva pozitivnim djelovanjem na 
održavanje normalne intestinalne mikroflore simulirajući imunološki sustav, te 
poboljšavaju nutritivnu vrijednost hrane proizvodnjom antimikrobnih 
supstanci (bakteriocina). Pored toga enterokoki predstavljaju rastući 
rezervoar oportunističkih patogena za ljude jer izazivaju bolesti, sadrže 
činitelje za antibiotičnu rezistenciju i mehanizme njihova transfera, te često 
nose i potencijalne virulentne faktore. Ali usprkos yin-yang naravi enterokoka, 
duga povijest bezopasne upotrebe pojedinih enterokoka u hrani i krmi, te 
pouzdana identifikacija i klasifikacija enterokoka fenotipskim metodama 
poduprtim modernim genetskim tehnikama, omogućava selekciju obećavajućih 
enterokoka, koje bi mogli, bez posebnog rizika po zdravlje čovjeka, upotrijebiti 
kao starterske kulture ili dodatke hrani i krmi.  
Ključne riječi: enterokoki, korisno i štetno djelovanje, identifikacija, 
klasifikacija, bezopasnost enterokoka  
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